NCT04184635View on ClinicalTrials.gov

Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

October 14, 2026

Study Completion Date

October 14, 2027

Conditions
Acute Myocardial InfarctionCardiogenic Shock
Interventions
DEVICE

VA-ECMO

"* The ECMO device will be the CardioHelp (MAQUET, GETINGE, Orléans, France) using the veno-arterial setting and percutaneous femoro-femoral cannulation with MAQUET GETINGE HLS cannulae.~* Intraortic balloon pump will be MEGA 50 cc or 40cc, (MAQUET, GETINGE, Orléans, France)."

Trial Locations (1)

75013

RECRUITING

Hôpital Pitié Salpétrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER